Trial Details

COMPLETED
Basic Information
Clinical ID c3898
Identifier NCT01355614
Trial Title A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: QAX576|DRUG: Infliximab
Participant Information
Sponsor Novartis Pharmaceuticals
City Germany
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-06
Primary Completion Date 2013-03
Completion Date 2013-03